- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.25 Å
- Oligo State
- monomer
- Ligands
- 1 x QW0: (~{E})-~{N}-[[5-(3-azanyl-1~{H}-indazol-6-yl)-4-chloranyl-1~{H}-imidazol-2-yl]methyl]-3-[5-chloranyl-2-(1,2,3,4-tetrazol-1-yl)phenyl]prop-2-enamide(Non-covalent)
- 1 x CIT: CITRIC ACID(Non-functional Binders)
- 4 x GOL: GLYCEROL(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Roehrig, S. et al., Design and Preclinical Characterization Program toward Asundexian (BAY 2433334), an Oral Factor XIa Inhibitor for the Prevention and Treatment of Thromboembolic Disorders. J.Med.Chem. (2023)
- Release Date
- 2023-09-13
- Peptides
- Coagulation factor XIa light chain: A
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AAA